Lv11
32 积分 2024-10-28 加入
Tumor-expressed B7-H3 mediates the inhibition of antitumor T-cell functions in ovarian cancer insensitive to PD-1 blockade therapy
7小时前
待确认
The CDK4/6 inhibitor revolution — a game-changing era for breast cancer treatment
2天前
已完结
Reversal of drug resistance by planetary ball milled (PBM) nanoparticle loaded with resveratrol and docetaxel in prostate cancer
2天前
已完结
Treatment advances across the cervical cancer spectrum
4天前
已完结
Recent advances in cervical cancer treatment: Innovations from early-stage to advanced disease
4天前
已完结
Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues
1个月前
已完结
Expression of Prostate‐Specific Membrane Antigen in Normal and Malignant Human Tissues
1个月前
已完结
Phase 1 Study of the Tissue Factor–Targeting Antibody-Drug Conjugate XB002 in Patients with Advanced Solid Tumors (JEWEL-101): Design of Expansion Cohorts for Squamous Cell Carcinoma of the Head and Neck
1个月前
已完结
Phase 1 Study of the Tissue Factor–Targeting Antibody-Drug Conjugate XB002 in Patients with Advanced Solid Tumors (JEWEL-101): Design of Expansion Cohorts for Squamous Cell Carcinoma of the Head and Neck
1个月前
已完结
ASN004, A 5T4-targeting scFv-Fc Antibody–Drug Conjugate with High Drug-to-Antibody Ratio, Induces Complete and Durable Tumor Regressions in Preclinical Models
1个月前
已完结
皖公网安备34019202002308
